Potential utility of plasma pTau217 for assessing amyloid and tau biomarker profiles

Key Points

• Plasma pTau217 correlates with amyloid pathology, indicating its potential as a relevant biomarker for assessing neurological conditions.
• The analysis conducted across various patient profiles demonstrates significant relationships between plasma pTau217 levels and tau pathology measures.
• Using advanced biomarker profiling, this study identifies plasma pTau217 as promising for understanding neurodegenerative diseases.
• Findings suggest that plasma pTau217 could enhance diagnostic tools for detecting amyloid and tau-related disorders.